Scientific Reports (Apr 2024)

SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

  • Chiu Wang Chau,
  • Alex To,
  • Rex K. H. Au-Yeung,
  • Kaiming Tang,
  • Yang Xiang,
  • Degong Ruan,
  • Lanlan Zhang,
  • Hera Wong,
  • Shihui Zhang,
  • Man Ting Au,
  • Seok Chung,
  • Euijeong Song,
  • Dong-Hee Choi,
  • Pentao Liu,
  • Shuofeng Yuan,
  • Chunyi Wen,
  • Ryohichi Sugimura

DOI
https://doi.org/10.1038/s41598-024-59405-9
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 8

Abstract

Read online

Abstract SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune cell activation and subsequent tissue damage is a significant task. Organoids from human tissues advanced our understanding of SARS-CoV-2 infection mechanisms though, they are missing crucial components: immune cells and endothelial cells. This study aims to generate organoids with these components. We established vascular immune organoids from human pluripotent stem cells and examined the effect of SARS-CoV-2 infection. We demonstrated that infections activated inflammatory macrophages. Notably, the upregulation of interferon signaling supports macrophages’ role in cytokine release syndrome. We propose vascular immune organoids are a useful platform to model and discover factors that ameliorate SARS-CoV-2-mediated cytokine release syndrome.